» Articles » PMID: 31784786

Relationship Between Bone Mineral Content and Bone Turnover Markers, Sex Hormones and Calciotropic Hormones in Pre- and Early Pubertal Children

Overview
Journal Osteoporos Int
Date 2019 Dec 1
PMID 31784786
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: It is still debated whether BM including bone turnover markers (BTM), sex hormones and calciotropic (including cortisol) hormones provide information on BMC changes during growth.

Methods: Three hundred fifty-seven girls and boys aged 6 to 13 years were included in this study. BM was measured at baseline and BMC twice at 9 months and 4 years using DXA. Relationship between BMs was assessed using principal component analysis (PCA). BM was tested in its ability to explain BMC variation by using structural equation modelling (SEM) on cross-sectional data. Longitudinal data were used to further assess the association between BM and BMC variables.

Results: BMC and all BMs, except calciotropic hormones, increased with age. PCA in BM revealed a three-factor solution (BTM, sex hormones and calciotropic hormones). In the SEM, age accounted for 61% and BTM for 1.2% of variance in BMC (cross-sectional). Neither sex nor calciotropic hormones were BMC explanatory variables. In the longitudinal models (with single BM as explanatory variables), BMC, age and sex at baseline accounted for 79-81% and 70-75% in BMC variance at 9 months and 4 years later, respectively. P1NP was consistently associated with BMC.

Conclusion: BMC strongly tracks in pre- and early pubertal children. In this study, only a small part of BMC variance was explained by single BTM at the beginning of pubertal growth.

Citing Articles

Reference Intervals (RIs) of the Bone Turnover Markers (BTMs) in Children and Adolescents: A Proposal for Effective Use.

Brescia V, Lovero R, Fontana A, Zerlotin R, Colucci S, Grano M Biomedicines. 2025; 13(1).

PMID: 39857618 PMC: 11759837. DOI: 10.3390/biomedicines13010034.


Bone Turnover Markers: Basic Biology to Clinical Applications.

Schini M, Vilaca T, Gossiel F, Salam S, Eastell R Endocr Rev. 2022; 44(3):417-473.

PMID: 36510335 PMC: 10166271. DOI: 10.1210/endrev/bnac031.

References
1.
Janssen M, Wielders J, Bekker C, Boesten L, Buijs M, Heijboer A . Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum. Steroids. 2012; 77(13):1366-72. DOI: 10.1016/j.steroids.2012.07.013. View

2.
Rasmussen A, Wohlfahrt-Veje C, Tefre de Renzy-Martin K, Hagen C, Tinggaard J, Mouritsen A . Validity of self-assessment of pubertal maturation. Pediatrics. 2014; 135(1):86-93. DOI: 10.1542/peds.2014-0793. View

3.
van Rijn R, van der Sluis I, Link T, Grampp S, Guglielmi G, Imhof H . Bone densitometry in children: a critical appraisal. Eur Radiol. 2003; 13(4):700-10. DOI: 10.1007/s00330-002-1676-8. View

4.
Weaver C, Gordon C, Janz K, Kalkwarf H, Lappe J, Lewis R . The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int. 2016; 27(4):1281-1386. PMC: 4791473. DOI: 10.1007/s00198-015-3440-3. View

5.
Vasikaran S, Eastell R, Bruyere O, Foldes A, Garnero P, Griesmacher A . Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2010; 22(2):391-420. DOI: 10.1007/s00198-010-1501-1. View